Fact CheckerSign in

NCT01169194Active, not recruiting

Multi-Center African-American Inflammatory Bowel Disease Study (MAAIS)

Source: ClinicalTrials.gov · Last updated 16 Jan 2026

Brief summary (registry, in English)

The investigators are doing the research to discover genes that cause Inflammatory Bowel Disease (IBD) specifically in the African American population. African Americans with or without Crohn's disease or ulcerative colitis are eligible to join. If you agree to join the study, the investigators will ask for information about your health. The investigators will also ask you to give us a blood sample so that they may discover the genes that cause IBD. The blood sample may be collected at Johns Hopkins or any local facility convenient to you.

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
2400 (estimated)
First submitted
16 Jun 2010
Start date
Jun 2003
Primary completion date
Aug 2027
Lead sponsor
Johns Hopkins University
NCT number
NCT01169194

What you commit to

  • Study type: Observational
  • Planned participants: 2400
  • From Jun 2003 to the primary completion date, Aug 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

  • African Americans with a confirmed diagnosis of Inflammatory Bowel Disease (IBD)
  • African Americans without a diagnosis of IBD and without a family history of IBD for comparison purposes

Age in the registry: 5 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Johns Hopkins University School Of Medicine
Coordinator of this site? Confirm its status
BaltimoreUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.